DIRECTOR
José Baselga Torres
RESEARCH TEAM
José Baselga Torres, Daniel A. Haber, Josep Tabernero.
COLLABORATING INSTITUTIONS
Massachusetts General Hospital
DESCRIPTION
The program will proceed along two main lines – new drug discovery and the improvement or optimized use of existing pharmaceutical therapies – with the common goals of securing more effective, individually tailored treatments and of accelerating their translation to the clinic, and thereby patient care.
Studies in this case will initially center on colorectal, breast and lung cancer, with the intention of expanding into other types like melanomas, lymphomas or prostate cancer.